The grant is designed to assist researchers in conducting new and innovative pilot projects that have potential for future support from foundations, corporations or government agencies. "This generous gift from Mallinckrodt helps pave the way for research that will lead to a better understanding of human disease and the development of life-saving treatments," said SNM President Mathew L. Thakur, Ph.D. "As partners, we demonstrate our commitment to helping the molecular imaging/nuclear medicine community advance research initiatives," he added.
"Research of this type is essential in expanding the use of molecular imaging and nuclear medicine to better serve patients, both now and in the future. Mallinckrodt is pleased to partner with SNM in this worthy endeavor," said Chris Wagner, group director of nuclear medicine at Mallinckrodt.
Eligible applicants are U.S. or international basic or clinical scientists employed by academic or research-oriented organizations. Applicants must hold a full-time faculty position in an educational institution when the award starts and must have completed all advanced training. Applicants must not have served as a principal investigator on grants totaling $50,000 or more in a single calendar year. Preference will be given to individuals who are in the early stages of their career and who have demonstrated great potential for a research career in the field of molecular imaging/nuclear medicine. No grantee may receive more than one grant in any one year. Likewise, no other grant request or continuation will b
Contact: Maryann Verrillo
Society of Nuclear Medicine